東華大學圖書館 |

Oxidative stress in lung diseases. Volume 1.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Oxidative stress in lung diseases/ edited by Sajal Chakraborti ... [et al.].
其他作者:	Chakraborti, Sajal.
出版者:	Singapore :Springer Singapore : : 2019.,
面頁冊數:	xx, 491 p. :ill., digital ;24 cm.
內容註:	Part A. General implications of oxidative stress on lungs -- Chapter 1. The nutrition in inflammatory lung diseases. Chapter 2. Oxidative Stress And Smoke Related Lung Diseases: A Tentative Approaches through blood, lungs and gut -- Chapter 3. Oxidative stress in neonatal lung diseases -- Chapter 4. DNA repair protein OGG1 in pulmonary infection and other inflammatory lung diseases -- Chapter 5. The dual role of oxidative stress in lung cancer -- Chapter 6. Cigarette smoke induced oxidative stress in type I and type II lung epithelial cells -- Chapter 7. Infectious lung diseases and Endogenous oxidative stress -- Chapter 8. Role of MMPs and Oxidants in Lung Diseases -- Chapter 9. Effect of exogenous chemical exposure-response relationship condensate oxidative stress in lung disease -- Part B. Inflammatory lung diseases -- Chapter 10. Oxidative stress and immune regulation during chronic respiratory diseases -- Chapter 11. Immunological basis of oxidative stress induced lung inflammation in asthma and COPD -- Chapter 12. Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases -- Chapter 13. Oxidative Stress and Pulmonary Carcinogenesis through Mechanisms of Reactive Oxygen Species. How Respirable Particulate Matter, Fibrous Dusts and Ozone Cause Pulmonary Inflammation and Initiate Lung Carcinogenesis -- Part C. Other lung diseases -- Chapter 14. The Redoxomics of Bronchopulmonary Dysplasia -- Chapter 15. Oxidative stress in environmental lung diseases -- Chapter 16. Bronchopulmonary Dysplasia and Oxidative Stress in the Newborn -- Chapter 17. Pulmonary Oxidative Stress and Antioxidant Defence System in the Lung Aging, and Fibrotic and Diabetic Lungs -- Chapter 18. Mitochondrial alterations and oxidative stress in cystic fibrosis -- Part D. Degenerative lung diseases -- Chapter 19. Oxidative stress in chronic obstructive pulmonary disease -- Chapter 20. Oxidative stress induced autophagy-impairment and pathogenesis of chronic obstructive lung diseases -- Part E. Prevention and Therapeutics -- Chapter 21. Therapeutic targeting of oxidative stress and inflammation in Asthma and COPD and Pharmacological interventions with Phytochemicals -- Chapter 22. Diallyl trisulfide prospectively rescues Arsenic induced lung oxidative stress, inflammation through the activation of Nrf2/HO-1 signaling -- Chapter 23. Molecular therapeutic targets in tobacco-induced lung pathology.
Contained By:	Springer Nature eBook
標題:	Lungs - Diseases. -
電子資源:	https://doi.org/10.1007/978-981-13-8413-4
ISBN:	9789811384134

Oxidative stress in lung diseases. Volume 1.
Oxidative stress in lung diseasesVolume 1.[electronic resource] /edited by Sajal Chakraborti ... [et al.]. - Singapore :Springer Singapore :2019. - xx, 491 p. :ill., digital ;24 cm.

Part A. General implications of oxidative stress on lungs -- Chapter 1. The nutrition in inflammatory lung diseases. Chapter 2. Oxidative Stress And Smoke Related Lung Diseases: A Tentative Approaches through blood, lungs and gut -- Chapter 3. Oxidative stress in neonatal lung diseases -- Chapter 4. DNA repair protein OGG1 in pulmonary infection and other inflammatory lung diseases -- Chapter 5. The dual role of oxidative stress in lung cancer -- Chapter 6. Cigarette smoke induced oxidative stress in type I and type II lung epithelial cells -- Chapter 7. Infectious lung diseases and Endogenous oxidative stress -- Chapter 8. Role of MMPs and Oxidants in Lung Diseases -- Chapter 9. Effect of exogenous chemical exposure-response relationship condensate oxidative stress in lung disease -- Part B. Inflammatory lung diseases -- Chapter 10. Oxidative stress and immune regulation during chronic respiratory diseases -- Chapter 11. Immunological basis of oxidative stress induced lung inflammation in asthma and COPD -- Chapter 12. Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases -- Chapter 13. Oxidative Stress and Pulmonary Carcinogenesis through Mechanisms of Reactive Oxygen Species. How Respirable Particulate Matter, Fibrous Dusts and Ozone Cause Pulmonary Inflammation and Initiate Lung Carcinogenesis -- Part C. Other lung diseases -- Chapter 14. The Redoxomics of Bronchopulmonary Dysplasia -- Chapter 15. Oxidative stress in environmental lung diseases -- Chapter 16. Bronchopulmonary Dysplasia and Oxidative Stress in the Newborn -- Chapter 17. Pulmonary Oxidative Stress and Antioxidant Defence System in the Lung Aging, and Fibrotic and Diabetic Lungs -- Chapter 18. Mitochondrial alterations and oxidative stress in cystic fibrosis -- Part D. Degenerative lung diseases -- Chapter 19. Oxidative stress in chronic obstructive pulmonary disease -- Chapter 20. Oxidative stress induced autophagy-impairment and pathogenesis of chronic obstructive lung diseases -- Part E. Prevention and Therapeutics -- Chapter 21. Therapeutic targeting of oxidative stress and inflammation in Asthma and COPD and Pharmacological interventions with Phytochemicals -- Chapter 22. Diallyl trisulfide prospectively rescues Arsenic induced lung oxidative stress, inflammation through the activation of Nrf2/HO-1 signaling -- Chapter 23. Molecular therapeutic targets in tobacco-induced lung pathology.

This first volume of the comprehensive, two-volume work on oxidative stress in lung disease introduces the molecular mechanisms, and the role of oxidants in the progression of different lung diseases. The lungs of humans and animals are under constant threat from oxidants from either endogenous (e.g. in situ metabolic reactions) or exogenous sources (e.g. air pollutants) Further, oxidative stress causes the oxidation of proteins, DNA and lipids, which in turn generates secondary metabolic products. The book consists of sections, each focusing on different aspects of oxidant-mediated lung diseases. As such it is a unique reference resource for postgraduate students, biomedical researchers and also for the clinicians who are interested in studying and understanding oxidant-mediated lung diseases. The second volume will incorporate other aspects of oxidant-mediated lung diseases, including prevention and therapeutics.

ISBN: 9789811384134

Standard No.: 10.1007/978-981-13-8413-4doiSubjects--Topical Terms:

1006034
Lungs
--Diseases.

LC Class. No.: RC756 / .O953 2019

Dewey Class. No.: 616.24

Oxidative stress in lung diseases. Volume 1.
LDR:04372nmm a2200325 a 4500 001 2242545
003 DE-He213
005 20200902160703.0
006 m d
007 cr nn 008maaau
008 211207s2019 si s 0 eng d
020 $a 9789811384134 $q (electronic bk.)
020 $a 9789811384127 $q (paper)
024 7 $a 10.1007/978-981-13-8413-4 $2 doi
035 $a 978-981-13-8413-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC756 $b .O953 2019
072 7 $a PSF $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a PSF $2 thema
082 0 4 $a 616.24 $2 23
090 $a RC756 $b .O98 2019
245 0 0 $a Oxidative stress in lung diseases $n Volume 1. $h [electronic resource] / $c edited by Sajal Chakraborti ... [et al.].
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2019.
300 $a xx, 491 p. : $b ill., digital ; $c 24 cm.
505 0 $a Part A. General implications of oxidative stress on lungs -- Chapter 1. The nutrition in inflammatory lung diseases. Chapter 2. Oxidative Stress And Smoke Related Lung Diseases: A Tentative Approaches through blood, lungs and gut -- Chapter 3. Oxidative stress in neonatal lung diseases -- Chapter 4. DNA repair protein OGG1 in pulmonary infection and other inflammatory lung diseases -- Chapter 5. The dual role of oxidative stress in lung cancer -- Chapter 6. Cigarette smoke induced oxidative stress in type I and type II lung epithelial cells -- Chapter 7. Infectious lung diseases and Endogenous oxidative stress -- Chapter 8. Role of MMPs and Oxidants in Lung Diseases -- Chapter 9. Effect of exogenous chemical exposure-response relationship condensate oxidative stress in lung disease -- Part B. Inflammatory lung diseases -- Chapter 10. Oxidative stress and immune regulation during chronic respiratory diseases -- Chapter 11. Immunological basis of oxidative stress induced lung inflammation in asthma and COPD -- Chapter 12. Contribution of Aldose Reductase-Mediated Oxidative Stress Signaling in Inflammatory Lung Diseases -- Chapter 13. Oxidative Stress and Pulmonary Carcinogenesis through Mechanisms of Reactive Oxygen Species. How Respirable Particulate Matter, Fibrous Dusts and Ozone Cause Pulmonary Inflammation and Initiate Lung Carcinogenesis -- Part C. Other lung diseases -- Chapter 14. The Redoxomics of Bronchopulmonary Dysplasia -- Chapter 15. Oxidative stress in environmental lung diseases -- Chapter 16. Bronchopulmonary Dysplasia and Oxidative Stress in the Newborn -- Chapter 17. Pulmonary Oxidative Stress and Antioxidant Defence System in the Lung Aging, and Fibrotic and Diabetic Lungs -- Chapter 18. Mitochondrial alterations and oxidative stress in cystic fibrosis -- Part D. Degenerative lung diseases -- Chapter 19. Oxidative stress in chronic obstructive pulmonary disease -- Chapter 20. Oxidative stress induced autophagy-impairment and pathogenesis of chronic obstructive lung diseases -- Part E. Prevention and Therapeutics -- Chapter 21. Therapeutic targeting of oxidative stress and inflammation in Asthma and COPD and Pharmacological interventions with Phytochemicals -- Chapter 22. Diallyl trisulfide prospectively rescues Arsenic induced lung oxidative stress, inflammation through the activation of Nrf2/HO-1 signaling -- Chapter 23. Molecular therapeutic targets in tobacco-induced lung pathology.
520 $a This first volume of the comprehensive, two-volume work on oxidative stress in lung disease introduces the molecular mechanisms, and the role of oxidants in the progression of different lung diseases. The lungs of humans and animals are under constant threat from oxidants from either endogenous (e.g. in situ metabolic reactions) or exogenous sources (e.g. air pollutants) Further, oxidative stress causes the oxidation of proteins, DNA and lipids, which in turn generates secondary metabolic products. The book consists of sections, each focusing on different aspects of oxidant-mediated lung diseases. As such it is a unique reference resource for postgraduate students, biomedical researchers and also for the clinicians who are interested in studying and understanding oxidant-mediated lung diseases. The second volume will incorporate other aspects of oxidant-mediated lung diseases, including prevention and therapeutics.
650 0 $a Lungs $x Diseases. $3 1006034
650 0 $a Oxidative stress. $3 899116
650 1 4 $a Oxidative Stress. $3 738786
650 2 4 $a Pneumology/Respiratory System. $3 894348
650 2 4 $a Human Physiology. $3 894102
650 2 4 $a Molecular Medicine. $3 890952
650 2 4 $a Medical Biochemistry. $3 892387
650 2 4 $a Biomedical Engineering/Biotechnology. $3 2162071
700 1 $a Chakraborti, Sajal. $3 2056425
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-13-8413-4
950 $a Biomedical and Life Sciences (SpringerNature-11642)